Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CG Oncology, Inc. - Common stock
(NQ:
CGON
)
57.34
+0.92 (+1.63%)
Streaming Delayed Price
Updated: 3:38 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CG Oncology, Inc. - Common stock
< Previous
1
2
Next >
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
January 09, 2026
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 06, 2026
From
CG Oncology Inc.
Via
GlobeNewswire
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
December 18, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer
December 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces New Board Member and Board Transition
November 26, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting
November 25, 2025
Two late-breaking podium presentations and three posters continue to demonstrate cretostimogene as a potential backbone therapy for a broad range of NMIBC patients
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates
November 14, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months
September 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Completes Enrollment in PIVOT-006
September 03, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
August 29, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 08, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
July 29, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
Via
Investor Brand Network
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
July 07, 2025
EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:REGN),(NASDAQ:VRTX),(OTCQX:RHHBY),(NYSE:MRK) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
June 18, 2025
Issued on behalf of Oncolytics Biotech Inc. Vancouver, BC – June 18, 2025 – USA News Group News Commentary – According to a recent report in Newsweek, more Americans younger than 50 are getting cancer....
Via
FinancialNewsMedia
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
May 15, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates
May 13, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
SUO-CTC and CG Oncology Announce the 2025 Award Recipients for the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 01, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting
April 26, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025
April 24, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
March 31, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
March 28, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
March 24, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
March 12, 2025
Late-breaking clinical and first translational data from BOND-003 Cohort C will be presented
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
February 26, 2025
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 16, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces Pricing of Public Offering
December 12, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
CG Oncology Announces Proposed Public Offering
December 11, 2024
From
CG Oncology Inc.
Via
GlobeNewswire
SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
December 06, 2024
Fellowship designed to support the development of outstanding clinical cancer research investigators to improve the understanding and treatment of NMIBC
From
CG Oncology Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
